Ghent University Academic Bibliography

Journal Article
A1
open access

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphne Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2026) CLINICAL MICROBIOLOGY AND INFECTION. 32(2). p.266-271

Add to list

Journal Article
A1
open access

Dose-limiting toxicities of paclitaxel in breast cancer patients : studying interactions between pharmacokinetics, physical activity, and body composition : a protocol for an observational cohort study

Len De Nys, Anita Barzegar-Fallah, Katrien Lanckmans, Stephane Steurbaut, David Beckwée, Amy de Haar-Holleman, Steven Provyn, Elke Gasthuys (UGent) , Sofie Vande Casteele (UGent) , Pieter-Jan De Sutter (UGent) , et al.

(2025) CANCERS. 17(1).

Add to list

Synergy of body composition, exercise oncology, and pharmacokinetics : a narrative review of personalizing paclitaxel treatment for breast cancer

Nele Adriaenssens, Stephanie C. M. Wuyts, Stephane Steurbaut, Pieter-Jan De Sutter (UGent) , An Vermeulen (UGent) , Amy de Haar-Holleman, David Beckwée, Steven Provyn, Sofie Vande Casteele (UGent) , Jinyu Zhou, et al.

(2025) CANCERS. 17(8).

Add to list

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphné Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2025) European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP), 21st Congress, Abstracts. In Pediatric Drugs 27(4). p.518-519

Add to list

Journal Article
A1
open access

Building Sub-Saharan African PBPK populations reveals critical data gaps : a case study on Aflatoxin B1

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2025) TOXINS. 17(10).

Add to list

Intraperitoneal aerosolized nanoliposomal irinotecan in patients with peritoneal metastases : preliminary pharmacokinetic results from a phase I trial

Judith van Ovost (UGent) , Pieter-Jan De Sutter (UGent) , Sarah Cosyns (UGent) , Sofie Vande Casteele (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) , Wouter Willaert (UGent) and Wim Ceelen (UGent)

(2025) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. In European Journal of Surgical Oncology 51(Supplement 2). p.15-16

Add to list

Unlocking diversity : towards a comprehensive framework for physiologically based pharmacokinetic population qualification in Sub Saharan Africa

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2024) Population Approach Group Europe (PAGE), 32nd Annual Conference 2023, Abstracts.

Add to list

Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis

Elke Gasthuys (UGent) , Judith van Ovost (UGent) , Sofie Vande Casteele (UGent) , Sarah Cosyns (UGent) , Wim Ceelen (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2024) JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 1233.

Add to list

Journal Article
A1
open access

Penetration of antibiotics into subcutaneous and intramuscular interstitial fluid : a meta-analysis of microdialysis studies in adults

Pieter-Jan De Sutter (UGent) , Eline Hermans (UGent) , Pieter De Cock (UGent) , Jan Van Bocxlaer (UGent) , Elke Gasthuys (UGent) and An Vermeulen (UGent)

(2024) CLINICAL PHARMACOKINETICS. 63(7). p.965-980

Add to list

Journal Article
A1
open access

Exploring the impact of efavirenz on aflatoxin B1 metabolism : insights from a physiologically based pharmacokinetic model and a human liver microsome study

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2024) TOXINS. 16(6).

Academic Bibliography

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Dose-limiting toxicities of paclitaxel in breast cancer patients : studying interactions between pharmacokinetics, physical activity, and body composition : a protocol for an observational cohort study

Synergy of body composition, exercise oncology, and pharmacokinetics : a narrative review of personalizing paclitaxel treatment for breast cancer

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Building Sub-Saharan African PBPK populations reveals critical data gaps : a case study on Aflatoxin B1

Intraperitoneal aerosolized nanoliposomal irinotecan in patients with peritoneal metastases : preliminary pharmacokinetic results from a phase I trial

Unlocking diversity : towards a comprehensive framework for physiologically based pharmacokinetic population qualification in Sub Saharan Africa

Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis

Penetration of antibiotics into subcutaneous and intramuscular interstitial fluid : a meta-analysis of microdialysis studies in adults

Exploring the impact of efavirenz on aflatoxin B1 metabolism : insights from a physiologically based pharmacokinetic model and a human liver microsome study

Contents

Support

Contact